Who owns ELAN
505 institutions reported holding ELAN for 2026Q1, together 108% of the company, more than the 473 a quarter earlier.
505
Institutions reporting a position · as of 2026Q1 · up from 473 the quarter before
- Shares held by institutions
- 544.9M
Shares held by institutions · 108% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $13.0B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 52%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 31
- New positions
- 89
- Positions exited
- 63
- Added to
- 178
- Reduced
- 146
- Top 10 holdersof the company
- 71%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 505 | 544.9M | $13.0B |
| 2025Q4 | 473 | 538.8M | $12.2B |
| 2025Q3 | 403 | 570.8M | $11.5B |
| 2025Q2 | 360 | 538.3M | $7.69B |
| 2025Q1 | 359 | 497.5M | $5.22B |
| 2024Q4 | 385 | 489.2M | $5.92B |
| 2024Q3 | 382 | 481.8M | $7.07B |
| 2024Q2 | 397 | 482.4M | $6.96B |
| 2024Q1 | 369 | 481.3M | $7.83B |
| 2023Q4 | 350 | 479.9M | $7.15B |
| 2023Q3 | 343 | 478.9M | $5.38B |
| 2023Q2 | 346 | 473.4M | $4.76B |
| 2023Q1 | 382 | 475.7M | $4.46B |
| 2022Q4 | 398 | 480.0M | $5.89B |
| 2022Q3 | 412 | 462.8M | $5.75B |
| 2022Q2 | 428 | 469.6M | $9.22B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Dodge & Cox | 68.9M | 14% | $1.65B |
| FMR LLC | 50.9M | 10% | $1.22B |
| VANGUARD GROUP INC | 48.9M | 9.7% | $1.17B |
| BlackRock Inc. | 47.6M | 9.4% | $1.14B |
| PRIMECAP MANAGEMENT CO/CA/ | 45.8M | 9.1% | $1.10B |
| T. Rowe Price Investment Management, Inc. | 34.6M | 6.8% | $829M |
| DIMENSIONAL FUND ADVISORS LP | 24.5M | 4.8% | $587M |
| STATE STREET CORP | 15.3M | 3.0% | $367M |
| Winslow Capital Management, LLC | 13.6M | 2.7% | $326M |
| GEODE CAPITAL MANAGEMENT LLC | 11.2M | 2.2% | $268M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #1 of 28 by Smart Score